THERAPEUTIC DRUG-MONITORING IN ONCOLOGY - PROBLEMS AND POTENTIAL IN ANTINEOPLASTIC THERAPY

被引：60

作者：

MOORE, MJ ^{[1
]}

ERLICHMAN, C ^{[1
]}

机构：

[1] UNIV TORONTO, DEPT MED & PHARMACOL, TORONTO M5S 1A1, ONTARIO, CANADA

来源：

CLINICAL PHARMACOKINETICS | 1987年 / 13卷 / 04期

关键词：

D O I：

10.2165/00003088-198713040-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：205 / 227

页数：23

共 178 条

[51]

ERLICHMAN C, 1987, IN PRESS CANCER CHEM

[52]

EVANS WE, 1984, LANCET, V1, P359

[53]

EVANS WE, 1978, CLIN PHARMACOL THER, V23, P68

[54] METHOTREXATE CEREBROSPINAL-FLUID AND SERUM CONCENTRATIONS AFTER INTERMEDIATE-DOSE METHOTREXATE INFUSION [J].

EVANS, WE ;

HUTSON, PR ;

STEWART, CF ;

CAIRNES, DA ;

BOWMAN, WP ;

RIVERA, G ;

CROM, WR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) :301-307

[55] PHARMACOKINETICS OF SUSTAINED SERUM METHOTREXATE CONCENTRATIONS SECONDARY TO GASTROINTESTINAL OBSTRUCTION [J].

EVANS, WE ;

TSIATIS, A ;

CROM, WR ;

BRODEUR, GM ;

COBURN, TC ;

PRATT, CB .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (11) :1194-1198

[56] CLINICAL PHARMACODYNAMICS OF HIGH-DOSE METHOTREXATE IN ACUTE LYMPHOCYTIC-LEUKEMIA - IDENTIFICATION OF A RELATION BETWEEN CONCENTRATION AND EFFECT [J].

EVANS, WE ;

CROM, WR ;

ABROMOWITCH, M ;

DODGE, R ;

LOOK, AT ;

BOWMAN, WP ;

GEORGE, SL ;

PUI, CH .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (08) :471-477

[57]

EVANS WE, 1986, P ASCO, V5, P194

[58]

EVANS WE, 1986, APPLIED PHARMACOKINE, P1009

[59]

EVANS WE, 1986, APPLIED PHARMACOKINE

[60] ORIGIN AND DEVELOPMENT OF HUMAN TUMORS STUDIED WITH CELL MARKERS [J].

FIALKOW, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (01) :26-34

← 1 2 3 4 5 6 7 8 9 10 →